Apellis Pharmaceuticals, Inc. (APLS) earnings
APLS earnings moved a median of +0.70% by the close. Quarterly and annual APLS reports and results, each read against the price at its own news timestamp. Back to the APLS overview →
27 measured APLS earnings events.
Where these APLS earnings landedvs 27 measured APLS earnings reactions
| Middle 50% of APLS earnings reactions | -2.93% to +5.84% |
|---|---|
| Median reaction (to close) | +0.70% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 APLS earnings events with a measured close landed between -2.93% and +5.84%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Apellis Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.05% | +0.07% | |
| Form 10-K/A Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.02% | +0.12% | |
| Form 10-K Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.34% | +5.78% | |
| Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results | Press release | +0.60% | -16.58% | |
| Form 10-Q Apellis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.60% | -16.58% | |
| Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results | Press release | -0.42% | -4.24% | |
| Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results | Press release | +5.42% | +8.18% | |
| Form 10-Q Apellis Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +5.42% | +8.18% | |
| Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results | Press release | +0.13% | +0.70% | |
| Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results | Press release | -0.06% | +4.84% | |
| Form 10-Q Apellis Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -0.06% | +4.84% | |
| Apellis Pharmaceuticals to Host Conference Call on May 7, 2025, to Discuss First Quarter 2025 Financial Results | Press release | +0.55% | +5.90% | |
| Form 10-K Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.64% | -3.19% | |
| Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results | Press release | +3.42% | +10.53% | |
| Form 10-Q Apellis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.42% | +10.53% | |
| Apellis Pharmaceuticals to Host Conference Call on November 5, 2024, to Discuss Third Quarter 2024 Financial Results | Press release | +1.09% | +3.68% | |
| Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results | Press release | -1.32% | -5.26% | |
| Form 10-Q Apellis Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.32% | -5.26% | |
| Apellis Pharmaceuticals to Host Conference Call on August 1, 2024, to Discuss Second Quarter 2024 Financial Results | Press release | -0.16% | -4.60% | |
| Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results | Press release | +4.41% | -2.66% | |
| Form 10-Q Apellis Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +4.41% | -2.66% | |
| Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results | Press release | +0.93% | +1.12% | |
| Form 10-K/A Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.23% | +1.64% | |
| Form 10-K Apellis Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.60% | -0.30% | |
| Apellis Pharmaceuticals Reports Third Quarter 2023 Financial Results | Press release | +5.38% | +8.29% | |
| Form 10-Q Apellis Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +5.38% | +8.29% | |
| Apellis Pharmaceuticals to Host Conference Call on November 1, 2023, to Discuss Third Quarter 2023 Financial Results | Press release | -0.13% | -1.10% |
Keep exploring
More APLS: analyst actions → · SEC filings → · APLS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ESSA Pharma Inc. (EPIX) | 718 | 0.00% | 38% |
| Tricida, Inc. (TCDA) | 715 | +0.06% | 51% |
| Enochian Biosciences, Inc. (ENOB) | 712 | 0.00% | 42% |
| LIFEPOINT HEALTH INC COMMON (LPNT) | 709 | +0.01% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.